Toniana G. Carvalho

Belo Horizonte, MG, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms.

Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms.

Journal: Gut microbes

Published: September 05, 2023

The role of annexin A1 in the modulation of the NLRP3 inflammasome.

The role of annexin A1 in the modulation of the NLRP3 inflammasome.

Journal: Immunology

Published: October 27, 2019

Metabotropic glutamate receptor 5 ablation accelerates age-related neurodegeneration and neuroinflammation.

Metabotropic glutamate receptor 5 ablation accelerates age-related neurodegeneration and neuroinflammation.

Journal: Neurochemistry international

Published: January 22, 2019

The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's disease.

The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's disease.

Journal: Journal of neurochemistry

Published: March 13, 2018

Zika Virus Promotes Neuronal Cell Death in a Non-Cell Autonomous Manner by Triggering the Release of Neurotoxic Factors.

Zika Virus Promotes Neuronal Cell Death in a Non-Cell Autonomous Manner by Triggering the Release of Neurotoxic Factors.

Journal: Frontiers in immunology

Published: June 29, 2017

mGluR5, CB1 and neuroprotection.

mGluR5, CB1 and neuroprotection.

Journal: Oncotarget

Published: December 29, 2016

Consumption of Diet Containing Free Amino Acids Exacerbates Colitis in Mice.

Consumption of Diet Containing Free Amino Acids Exacerbates Colitis in Mice.

Journal: Frontiers in immunology

Published: December 16, 2016

The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.

The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.

Journal: Neurobiology of disease

Published: May 09, 2014

Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.

Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.

Journal: British journal of pharmacology

Published: October 04, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026